Prostatic Neoplasms: all 6,484 studies
Page 61 of 65. Open to participants first (1,415), then studies with results posted, then the rest; newest registration first within each.
- Palladium-103 Seed Implant and Single Daily Dosing of Uroxatral Vs. Twice Daily Dosing of Flomax- A 3 Month Retrospective Efficacy AnalysisCompletedNCT00264017
- The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte CancerActive, not recruitingNCT00261456
- Study of Oxaliplatin and Taxotere in Prostate CancerCompletedNCT00260611Phase 2
- Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy.TerminatedNCT00258765Phase 2
- Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate CancerWithdrawnNCT00258466Phase 3
- Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.CompletedNCT00258401Not applicable
- Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone TherapyCompletedNCT00258388Phase 2
- Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate CancerCompletedNCT00258284Phase 2
- A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With ChemotherapyCompletedNCT00257478Phase 2
- Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate CancerCompletedNCT00255606Phase 3
- CMAB vs IMAB in Metastatic Prostate CancerWithdrawnNCT00255268Phase 4
- Exercise in Men Receiving Radiation Therapy for Prostate Cancer.CompletedNCT00253916Not applicable
- Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate AdenocarcinomaCompletedNCT00252941Phase 1/2
- CT/MRI Co-registration Prostate CancerCompletedNCT00252460
- Preop Conformal Radiotherapy - ProstateCompletedNCT00252447Phase 1/2
- Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic SecretionsTerminatedNCT00250757
- Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol IICompletedNCT00250224Phase 1
- Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized TrialCompletedNCT00247312Phase 3
- Study of Aranesp to Treat Anemia in Prostate Cancer Patients.CompletedNCT00245895Phase 2
- Fulvestrant in Treating Patients With Advanced Prostate CancerCompletedNCT00244998Phase 2
- Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate CancerWithdrawnNCT00244920Phase 2
- Acupuncture in Treating Hot Flashes in Patients With Prostate CancerTerminatedNCT00244894Not applicable
- Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate CancerCompletedNCT00244309Phase 3
- Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized TrialTerminatedNCT00243646Phase 3
- High Dose-Rate Brachytherapy and/or Intensity Modulated External Beam Radiation Therapy for Prostate CancerCompletedNCT00243321Not applicable
- Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate CancerCompletedNCT00243048Phase 2
- Flu/TBI in Treating Patients Not Responding to Previous Hormone TherapyWithdrawnNCT00242931Phase 2
- Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerCompletedNCT00242918Phase 2
- Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone MetastasesCompletedNCT00242554Phase 4
- Erectile Dysfunction/Prostate/RT/AndrogenCompletedNCT00242138Phase 2
- Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRICompletedNCT00242112Not applicable
- The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate CancerCompletedNCT00242073Not applicable
- Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative BiopsyCompletedNCT00242060Not applicable
- Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or RadiotherapyCompletedNCT00241475Phase 2
- Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate CancerCompletedNCT00241384Phase 3
- Assessment of the Efficacy, Tolerability and Pharmaco-economic Impact of Zoledronic Acid Treatment in Prostate Cancer With Bone MetastasisCompletedNCT00241111Phase 4
- Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate CancerCompletedNCT00239291Phase 1/2
- Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone MetastasisCompletedNCT00237159Phase 4
- Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone OrchiectomyCompletedNCT00237146Phase 4
- An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer PatientsCompletedNCT00235794Not applicable
- Effects of ASA on Prostate TissueCompletedNCT00234299Not applicable
- Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate CancerCompletedNCT00233610Phase 3
- External Beam Radiation Therapy - Target VolumeCompletedNCT00230438Phase 2
- Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate CarcinomaCompletedNCT00230386Phase 1/2
- PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body CompositionStatus unknownNCT00228124
- Duration of Androgen Blockade Combined with Pelvic Irradiation in Prostate CancersActive, not recruitingNCT00223171Phase 3
- Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy AloneActive, not recruitingNCT00223145Phase 3
- A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate CancerCompletedNCT00220194Phase 4
- Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate CancerCompletedNCT00219271Phase 4
- Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone MetastasesCompletedNCT00219219Phase 4
- A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate CancerStatus unknownNCT00218205Phase 2
- Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate CancerCompletedNCT00217516Phase 1
- Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate CancerCompletedNCT00215709Phase 1
- Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?TerminatedNCT00215631Phase 3
- A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate CancerStatus unknownNCT00215345Phase 2
- CHESS Caregivers Study: Web-based Support for Informal Caregivers in CancerCompletedNCT00214162Not applicable
- PROSTACOX : Metastatic Prostate ChemotherapyCompletedNCT00213694
- A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer ScreeningCompletedNCT00208988Not applicable
- Shared Decision Making: Prostate Cancer ScreeningCompletedNCT00207649Not applicable
- Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility TrialCompletedNCT00207259Not applicable
- Prostate Cancer Utilities and Cost-Effectiveness AnalysisCompletedNCT00203918
- Shorter Radiation Schedule for the Treatment of Prostate CancerCompletedNCT00201916Phase 3
- Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing BrachytherapyStatus unknownNCT00201630Phase 3
- An Open Trial to Assess the Efficacy and Safety of Oral Thalidomide in Patients With Hormone-Refractory Prostate CancerCompletedNCT00201357Phase 2
- Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone HealthCompletedNCT00200824Phase 2
- Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate CancerCompletedNCT00199537
- Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate CancerCompletedNCT00199485Phase 4
- Prostate Cancer Screening: Fostering Informed DecisionsCompletedNCT00196807Phase 3
- Treatment Decision Making in Early-Stage Prostate CancerCompletedNCT00196781Phase 3
- A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer PatientsCompletedNCT00196339Phase 2
- RADAR Trial - Randomised Androgen Deprivation and RadiotherapyCompletedNCT00193856Phase 3
- Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate CancerCompletedNCT00193271Phase 2
- Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate CancerCompletedNCT00193232Phase 2
- Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate CarcinomaCompletedNCT00193193Phase 2
- Xray Volume Imaging (Cone Beam CT) - Prostate CancerCompletedNCT00188799Phase 2
- Cone Beam CT for Daily Image Guidance - Prostate CancerCompletedNCT00188786Phase 2
- Effect of Casodex on Tumour Hypoxia - Prostate CancerCompletedNCT00188708Not applicable
- Combidex USPIO - Ultra-small Superparamagnetic Iron OxideCompletedNCT00188695Phase 1/2
- Intensity Modulated Radiation Therapy - Prostate CancerCompletedNCT00188513Phase 1/2
- Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and RadiationCompletedNCT00186420Phase 2
- Microarray Analysis of Gene Expression in Prostate TissuesCompletedNCT00186368
- A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate CancerCompletedNCT00186108Phase 1
- MR-Lymphography and Lymph Node Staging in Prostate CancerStatus unknownNCT00185029Phase 4
- Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate CancerCompletedNCT00182741Phase 2
- Magnetic Resonance Imaging to Evaluate Prostate CancerCompletedNCT00182624
- Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate CancerCompletedNCT00182052Phase 3
- Trilostane for Androgen-Independent Prostate CancerCompletedNCT00181597Phase 2
- Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate CancerCompletedNCT00181584Phase 2
- Atrasentan and Zometa for Men With Prostate Cancer Metastatic to BoneCompletedNCT00181558Phase 2
- A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.TerminatedNCT00179738Phase 2
- Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)CompletedNCT00177619Phase 3
- Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRPCompletedNCT00177125Phase 3
- Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate CancerCompletedNCT00176579
- Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone TherapyTerminatedNCT00176527Phase 2
- Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate CancerTerminatedNCT00176293Phase 2
- Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation TherapyStatus unknownNCT00175396Phase 3
- Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate CancerCompletedNCT00175383Not applicable
- Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate CancerCompletedNCT00174863Phase 2
- Study to Assess Efficacy and Safety of Zoledronic Acid and the Value of Markers of Bone Resorption in the Prediction of Bone Metastases and Cancer Treatment-induced Bone Loss (CTIBL) in Patients With Prostate Cancer on Hormone TherapyCompletedNCT00172055Phase 3
- A Study to Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as BisphosphonatesCompletedNCT00172016Phase 4